lysat
cultur
cell
analyz
argininespecif
endoproteas
use
peptidylpnitroanilid
chromogen
substrat
enzym
present
mdbk
mdck
vero
bhk
chick
embryo
cell
requir
lysinearginin
argininearginin
pair
cleavag
site
wherea
chorioallanto
membran
cell
contain
addit
activ
could
cleav
singl
arginin
effect
peptidyl
chloroalkyl
keton
activ
fowl
plagu
viru
hemagglutinin
proteas
specif
pair
basic
residu
investig
virion
contain
uncleav
hemagglutinin
incub
lysat
uninfect
cell
cleavag
complet
inhibit
peptidyl
chloroalkyl
keton
contain
pair
basic
residu
concentr
mm
contrast
compound
contain
singl
arginin
inhibitori
activ
dibas
peptidyl
chloroalkyl
keton
ad
infect
cell
cultur
cleavag
hemagglutinin
multipl
cycl
viru
replic
inhibit
mm
howev
ooto
increas
inhibitori
activ
intact
cell
could
achiev
ntermin
acyl
studi
suggest
potenti
role
peptidyl
chloroalkyl
keton
antivir
agent
q
pw
ic
biosynthesi
hemagglutinin
influenza
viru
involv
posttransl
proteolyt
cleavag
precursor
ha
subunit
ha
ha
cleavag
necessari
express
fusion
capac
hemagglutinin
thu
initi
infect
klenk
et
lazarowitz
choppin
two
host
enzym
involv
cleavag
first
ttypsinlik
endoproteas
act
distinct
arginineglycin
bond
subsequ
carboxypeptidas
elimin
basic
amino
acid
cleavag
site
proteolyt
activ
prove
high
import
spread
infect
pathogen
hemagglutinin
mammalian
apathogen
avian
influenza
virus
caus
local
infect
cleav
restrict
number
cell
type
contrast
hemagglutinin
pathogen
avian
influenza
virus
caus
system
infect
activ
broad
rang
differ
host
cell
import
determin
differ
proteolyt
activ
structur
cleavag
site
hemagglutinin
specif
endoproteas
present
individu
cell
hemagglutinin
apathogen
avian
mammalian
influenza
virus
singl
arginin
residu
cleavag
site
recogn
enzym
present
ceil
wherea
request
reprint
address
hemagglutinin
pathogen
avian
influenza
virus
cleavag
site
consist
sever
basic
amino
acid
cleav
endoproteas
present
mani
cell
review
see
klenk
rott
posttransl
proteolyt
cleavag
multipl
basic
residu
appear
gener
principl
mani
hormon
enzym
biolog
import
peptid
protein
activ
docherti
et
herbert
uhler
type
cleavag
also
observ
whole
seri
viral
glycoprotein
includ
f
protein
paramyxovirus
scheid
choppin
paterson
et
al
precursor
protein
coronavirus
binn
et
al
surfac
glycoprotein
arenavirus
romanowski
et
al
env
protein
retrovirus
shinnick
et
al
minim
consensu
sequenc
serv
recognit
signal
convert
enzym
appear
pair
basic
amino
acid
frequent
lysinearginin
argininearginin
howev
length
basic
peptid
cleavag
site
often
exce
amino
acid
avail
evid
indic
addit
basic
residu
may
increas
cleavabl
kawaoka
et
al
pathogen
ohuchi
et
al
peptidyl
chloroalkyl
keton
potent
proteas
inhibitor
coval
label
substrat
bind
site
proteolyt
enzym
consider
specif
inactiv
trypsinlik
enzym
involv
coagul
fibrinolysi
obtain
modifi
peptidyl
moieti
reagent
kettner
shaw
present
studi
analyz
effect
variou
peptidyl
chloroalkyl
keton
hemagglutinin
cleavag
replic
pathogen
avian
influenza
viru
fowl
plagu
viru
show
compound
contain
pair
basic
amino
acid
effect
inhibitor
influenza
viru
strain
dobson
variant
adapt
growth
bhk
cell
use
seed
stock
propag
allanto
caviti
dayold
embryon
egg
dutch
strain
grown
f
cell
presenc
ionophor
calbiothem
frankfurt
ad
reinforc
eagl
medium
rem
lack
calcium
chlorid
viru
uncleav
hemagglutinin
need
klenk
eta
restock
strain
grown
confluent
monolay
chicken
embryo
cell
cec
obtain
radioact
viru
particl
methionin
iml
glucosamin
iml
ad
methioninefre
medium
medium
glucos
replac
mlvi
fructos
respect
metabol
label
methionin
cell
deplet
methionin
min
viru
releas
supernat
cell
cultur
collect
centrifug
purifi
sucros
gradient
klenk
et
al
viru
propag
presenc
peptidyl
chloroalkyl
keton
inhibitor
solubil
mm
hci
except
palmitoyl
one
dissolv
dimethyl
sulfoxid
stock
solut
peptidyl
chloroalkyl
keton
store
dilut
ofold
pb
rem
use
palmitoyl
inhibitor
ad
medium
dispers
ultrasonif
branson
sonifi
set
w
hemagglutin
plaqu
assay
carri
quantif
viru
accord
standard
procedur
sampl
contain
radioact
label
viral
glycoprotein
analyz
sdspage
laemmli
directli
immunoprecipit
gel
contain
acrylamid
bisacrylamid
treat
gel
enhanc
new
england
nuclear
fluorographi
carri
kodak
xomat
ar
film
nonradioact
viral
protein
analyz
immunoblot
kuroda
et
immunoblot
immunoprecipit
rabbit
antiserum
fpv
restock
strain
use
monolay
cultur
cec
chorioallanto
membran
cam
cell
klenket
variou
cell
type
scrape
petri
dish
diamet
resuspend
ml
pb
contain
mm
caci
noctylglucosid
cell
sonic
branson
sonifi
set
immedi
use
assay
klenk
et
follow
chromogen
substrat
purchas
bachem
bubendorf
switzerland
use
vcbzltyrosylllysyllargininepnitroanilid
cbzykrpna
ncbzr
arginyllargininepnitroanilid
cbzrrpna
ivcbzlargininepnitroanilid
cbzrpna
aqueou
solut
substrat
ad
cell
lysat
total
volum
contain
mm
caci
incub
hr
reaction
mixtur
centrifug
g
min
optic
densiti
supernat
measur
nm
hemagglutinin
use
substrat
hau
radioact
label
fpv
dutch
strain
contain
uncleav
hemagglutinin
incub
pb
cell
lysat
presenc
mlli
caci
klenk
et
al
proteolyt
cleavag
stop
ad
sampl
buffer
contain
sd
dithiothreitol
electrophoresi
sampl
boil
min
appli
slab
gel
proport
uncleav
proteolyt
cleav
hemagglutinin
proteas
treatment
estim
scan
fluorographi
biorad
model
videodensitomet
alanyllysylarginyl
chloromethyl
keton
akrcmk
tyrosylalanyllysylarginyl
chloromethyl
keton
yakrcmk
phenylalanylalanyllysylarginyl
chloromethyl
keton
fakrcmk
alanylphenylalanylarginyl
chloromethyl
keton
afrcmk
synthes
describ
kettner
shaw
phenylalanylalanyllysylarginyl
chloroethyl
keton
fakrcek
palmitoylphenylalanylalanyllysylarginyl
chloroethyl
keton
palfakrcek
prepar
relat
procedur
wikstrom
et
peptic
pnitroanilid
mnl
incub
cell
lysat
pb
contain
caci
noctylglucosid
hr
extinct
ofpnitroanrlrn
measur
nm
valu
indic
percentag
cleavag
rel
total
cleavag
obtarn
incub
substrat
trypsin
pgml
character
proteas
respons
activ
fpv
hemagglutinin
use
viru
uncleav
glycoprotein
substrat
previou
work
viru
grown
presenc
calciumspecif
ionophor
klenk
et
obtain
small
amount
furthermor
ceil
lysat
employ
studi
like
contain
wide
spectrum
differ
proteas
known
influenza
viru
hemagglutinin
cleav
fragment
similar
size
ha
ha
sever
nonactiv
enzym
differ
substrat
specif
trypsinlik
proteas
garten
et
al
reason
use
addit
viru
grown
presenc
chromogen
peptid
mimick
cleavag
site
altern
substrat
present
studi
shown
tabl
peptidylpnitroanilid
contain
two
basic
amino
acid
cleav
lysat
obtain
cell
analyz
differ
rel
cleav
activ
individu
cell
line
mdbk
bhk
cell
extrem
end
variat
sequenc
two
basic
residu
argininearginin
versu
lysinearginin
tabl
ntermin
elong
peptid
ad
sever
uncharg
amino
acid
alanin
tyrosin
data
shown
signific
effect
substrat
specif
howev
basic
sequenc
reduc
singl
arginin
peptid
lost
function
substrat
cell
except
cam
cell
thu
chromogen
peptid
resembl
close
differenti
substrat
specif
influenza
viru
hemagglutinin
among
contain
singl
arginin
also
cleav
cam
cell
wherea
contain
sever
basic
residu
usual
cleav
mani
cell
chromogen
peptid
therefor
suitabl
substrat
proteas
activ
hemagglutinin
shown
peptidyl
chloroalkyl
keton
amino
acid
sequenc
analog
physiolog
substrat
specif
inactiv
correspond
serin
proteas
kettner
shaw
therefor
use
substanc
inhibit
proteas
activ
hemagglutinin
tabl
show
experi
cell
lysat
first
incub
akrcmk
inhibitor
subsequ
chromogen
substrat
contain
also
two
basic
residu
cleavag
site
data
indic
inhibitor
concentr
mm
proteolyt
activ
inhibit
oo
respect
use
hemagglutinin
substrat
analyz
effect
variou
peptidyl
chloroalkyl
keton
proteas
cell
lysat
tabl
show
compound
includ
palmitoyl
deriv
inhibitori
activ
contain
pair
basic
residu
contrast
keton
singl
arginin
ineffect
observ
indic
specif
inhibitor
vari
depend
number
basic
residu
case
substrat
specif
proteas
interfer
enzymat
activ
lysat
preincub
inhibitor
assay
describ
materi
method
substrat
use
concentr
note
purifi
fpv
dobson
variant
uncleav
hemagglutinin
grown
bhk
cell
presenc
pm
glucosamin
iml
incub
mdbk
cell
lysat
describ
materi
method
incub
viru
cell
lysat
pretreat
room
temperatur
min
variou
concentr
inhibitor
indic
watersolubl
inhibitor
dissolv
hci
acyl
inhibitor
dimethyl
sulfoxid
thereaft
virion
disintegr
sampl
buffer
reduc
condit
viral
protein
analyz
sdspage
fluorographi
cleav
uncleav
hemagglutinin
quantit
densitometri
differ
amount
uncleav
hemagglutinin
found
untreat
viru
viru
expos
cell
lysat
absenc
inhibitor
consid
cleavag
interest
find
whether
peptidyl
chloroalkyl
keton
abl
interfer
hemagglutinin
process
cours
viru
replic
intact
cell
pretreat
fakrcmk
hr
monolay
ce
cell
infect
fpv
singl
replic
cycl
condit
viru
releas
cultur
purifi
analyz
polypeptid
composit
fig
essenti
result
obtain
restock
strain
shown
dutch
strain
data
shown
use
inhibitor
present
infect
viru
uncleav
hemagglutinin
produc
obtain
complet
inhibit
cleavag
inhibitor
concentr
mm
need
fig
b
inhibitor
remov
cell
cultur
pretreat
viru
produc
cleav
hemagglutinin
fig
case
control
experi
perform
without
inhibitor
fig
lc
incub
inhibitor
result
signific
reduct
viru
releas
measur
hemagglutin
titer
media
even
extend
inhibitor
pretreat
much
day
littl
effect
cell
observ
indic
fakrcmk
prevent
cleavag
cell
lysat
also
infect
intact
cell
furthermor
fakrcmk
show
littl
toxic
cell
cultur
monobas
inhibitor
farcmk
contrast
prove
quit
toxic
alreadi
concentr
mm
cell
sever
damag
longer
allow
viru
replic
intracellular
compartment
membran
anchorag
cleavag
enzym
klenk
et
al
may
explain
rel
high
concentr
water
solubl
inhibitor
mm
need
prevent
hemagglutinin
cleavag
cell
cultur
amphophil
charact
acyl
compound
palfakrcek
better
enzym
access
intact
cell
point
tabl
inhibitor
use
similar
amount
water
solubl
compound
effect
cell
lysat
howev
ad
cell
infect
restock
strain
palfakrcek
caus
total
inhibit
cleavag
alreadi
concentr
pm
fig
wherea
mm
requir
fakrcmk
fig
even
concentr
palfakrcek
partial
inhibit
still
observ
fig
similar
result
obtain
dutch
strain
data
shown
thu
clear
acyl
enhanc
inhibitori
effect
intact
cell
pfuml
incub
dulbecco
medium
contain
pm
b
palfakrcmk
hr
medium
replac
rem
without
methionin
still
contain
inhibitor
respect
concentr
min
iml
methionin
ad
hr
viral
protein
immunoprecipit
cell
lysat
analyz
sdspage
control
experi
carri
absenc
inhibitor
also
shown
c
sinc
inhibit
hemagglutinin
cleavag
accomplish
interest
find
whether
compound
interfer
spread
viru
infect
viru
therefor
propag
ce
cell
cultur
condit
multipl
cycl
replic
effect
inhibitor
viru
growth
analyz
essenti
result
obtain
restock
dutch
strain
shown
fig
fakrcmk
ad
cultur
concentr
mm
obtain
signific
effect
effici
inhibitor
could
alter
replac
methyl
ethyl
group
ad
uncharg
amino
acid
aminotermin
end
peptid
data
shown
howev
acyl
peptid
result
distinct
increas
inhibitori
activ
fig
observ
viru
product
retard
complet
suppress
even
effect
inhibitori
condit
like
explain
gradual
degrad
peptidyl
chloroalkyl
keton
cell
cultur
demonstr
dibas
peptidyl
chloroalkyl
keton
inhibit
cleavag
activ
fpv
hemagglutinin
result
obtain
analyz
hemagglutinin
process
first
ce
cell
cultur
infect
restock
dutch
strain
viru
second
vitro
system
use
lysat
mdbk
cell
virion
dutch
strain
contain
uncleav
hemagglutinin
precursor
klenk
et
al
sinc
hemagglutinin
essenti
cleavag
site
restock
dutch
strain
klenk
rott
legitim
compar
result
obtain
system
specif
peptidyl
chloroalkyl
keton
shown
previou
studi
use
agent
select
inactiv
character
viral
korant
et
al
cellular
cystein
serin
proteinas
latter
group
proteinas
includ
trypsin
plasmin
acrosin
sever
bacteri
proteinas
certain
condit
may
also
serv
activ
enzym
lazarowitz
et
al
klenk
et
garten
et
al
tashiro
et
b
report
tamino
caproic
acid
aprotinin
interfer
activ
influenza
viru
hemagglutinin
plasmin
present
alveolar
fluid
zhirnov
et
b
leupeptin
inhibit
proteinas
secret
coinfect
bacteria
tashiro
et
al
b
contrast
inhibitor
act
extracellular
space
peptidyl
chloroalkyl
keton
use
present
studi
block
intracellular
enzym
observ
palmitoyl
deriv
inhibitor
loofold
effect
free
form
support
previou
find
enzym
bound
cellular
membran
also
report
proteas
calciumdepend
act
neutral
ph
klenk
et
cleavag
fpv
hemagglutinin
late
event
intracellular
transport
assum
occur
shortli
glycoprotein
arriv
plasma
membran
klenk
et
al
enzym
respons
activ
fpv
hemagglutinin
show
number
strike
similar
subcellular
locat
catalyt
properti
enzym
believ
process
prohormon
pair
basic
residu
endocrin
tissu
proteas
cleav
insulin
precursor
isol
secretori
granula
pancreat
p
cell
found
control
intraorganellar
calcium
ph
davidson
et
al
davidson
et
al
proteas
isol
secretori
vesicl
bovin
pituitari
neural
lobe
cleav
protein
peptid
neutral
ph
parish
et
al
afactor
matrng
pheromon
peptid
hormon
yeast
activ
pair
basic
residu
membranebound
serin
proteas
strictli
calciumdepend
neutral
ph
optimum
thoma
et
exactli
observ
activ
enzym
fpv
hemagglutinin
therefor
reason
assum
remain
proven
enzym
activ
viral
glycoprotein
peptid
hormon
belong
famili
proteinas
data
show
enzym
cleav
peptidylpnitroanilid
similar
substrat
specif
influenza
viru
hemagglutinin
thu
chromogen
may
substitut
hemagglutinin
larg
amount
substrat
requir
may
case
instanc
studi
aim
character
activ
proteinas
point
larg
number
viral
glycoprotein
cleav
cellular
proteas
argininearginin
lysinearginin
site
interest
see
whether
cleavag
glycoprotein
also
inhibit
compound
analyz
mani
virus
eg
togavirus
coronavirus
arenavirus
herp
virus
retrovirus
biolog
signific
cleavag
reaction
understood
studi
inhibitor
type
analyz
throw
light
problem
case
cleavag
protein
argininecontain
site
suspect
definit
proven
use
peptidyl
chloroalkyl
keton
might
result
accumul
polypeptid
far
identifi
precursor
inhibitor
might
thu
also
help
elucid
new
precursorproduct
relationship
list
virus
depend
proteolyt
activ
glycoprotein
spread
organ
includ
hiv
mccune
et
al
mani
import
pathogen
applic
peptidyl
chloroalkyl
keton
antivir
agent
therefor
worth
consid
alreadi
point
avail
evid
indic
cleavag
activ
arginin
residu
mechan
also
essenti
cellular
function
regul
peptidyl
chloroalkyl
keton
therefor
usual
consid
toxic
applic
therapeut
purpos
may
feasibl
howev
shown
activ
fpv
hemagglutinin
block
fakrcmk
fakcmk
thu
data
provid
evid
sequencespecif
point
viral
cellular
protein
cleavag
site
consist
pair
whole
seri
basic
residu
may
contribut
specif
recognit
signal
activ
proteinas
furthermor
among
differ
protein
consider
sequenc
variat
connect
peptid
may
therefor
desir
construct
chloroalkyl
keton
extend
peptid
show
exact
homolog
specif
cleavag
site
inhibitor
may
select
among
proteas
interact
thu
less
toxic
